Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
An overview of index funds with the lowest fees for retirement in 2024, highlighting how fees affect long-term returns and what to consider.
27,284 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Micron Technology shares tumbled about 13% ahead of its fiscal Q3 print, but one analyst argues the slide is a sentim...
Apple stock just dropped as memory costs surge and device pricing shifts bite into margins. Traders weigh supply-chai...
Ripple's XRP Ledger is moving toward an on-chain lending layer. This article explains how the ledger's 'missing layer...
NVIDIA is accelerating its on-device AI push, signaling a potential TAM expansion as edge computing moves from theory...
SpaceX blends rockets, satellites, and AI dreams. This piece examines whether could spacex eventually become the top ...
Investors wonder about the path ahead for Lucid stock. This guide lays out three scenarios, the key drivers, and conc...
Federal economists say tariffs are unlikely to be a one-off hit. Instead, a trump created ‘trickle up’ pricing approa...
Figma posted impressive numbers in early 2026, yet the stock slumped. This article breaks down the drivers behind fig...
With Senate leadership sidelined, key defense funding plans face delay as Iran tensions intensify and midterms loom. ...
Jim Cramer challenges a fresh downgrade on Apple, arguing the stock’s AI ambitions and a possible 2027 supercycle jus...
A widening gap between data-center demand and supply is boosting heavy equipment and power-management stocks. Discove...